Estimation of the gene frequency of aceruloplasminemia in Japan

Neurology

Volumn 53, Issue 3, 1999, Pages 617-619

  Miyajima, Hiroaki ^a   Kohno, S ^a   Takahashi, Y ^a   Yonekawa, O ^a   Kanno, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN;

ACERULOPLASMINEMIA; ADULT; AGED; ALLELE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; DIABETES MELLITUS; ENZYME DEFICIENCY; GENE FREQUENCY; HUMAN; IRON METABOLISM; JAPAN; MAJOR CLINICAL STUDY; NERVE DEGENERATION; PRIORITY JOURNAL; RETINA DEGENERATION;

EID: 0033546624     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.3.617     Document Type: Article

References (10)

1. Kawanami T, Kato T, Daimon M, et al. Hereditary caeruloplasmin deficiency: clinicopathological study of a patient. J Neurol Neurosurg Psychiatry 1996;61:506-509.
2. Connor JR, Benkovic SA. Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 1992;32:51-61.
3. ∈-(carboxymethyl)lysine formation from Amadon product. Biochem Biophys Res Commun 1997;234:167-172.
4. ∈-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996;35:8076-8083.
5. Kume S, Takeya M, Mori T, et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 1995;147:654-667.
6. Makino H, Shikata K, Hironaka K, et al. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 1995;48:517-526.
7. Kiomp LWJ, Farhangrazi ZS, Dugan LL, Gitlm JD. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 1996;98:207-215.
8. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now?. L Lab Clin Med 1992;119:598-620.
9. Horiuchi S, Higashi T, Ikeda K, et al. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes 1996;3:S73-S76.
10. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997;46: 1733-1742.